However, further survival analysis after the homogenization of both collectives showed that the platinum-treated cohort had a highly significant shorter PFS compared to the untreated group, so the data appear valid despite the small case number.
← all excerpts
<i>ERBB2</i> Amplification as a Predictive and Prognostic Biomarker in Upper Tract Urothelial Carcinoma.
1
—
—